reSee.it - Related Video Feed

mRNA vaccines, like the ones developed for the pandemic, have brought attention to the potential of gene and cell therapy. Previously, if we had asked the public if they would be willing to receive such treatments, the majority would have refused. However, the pandemic has changed people's perspectives and made them more open to innovative approaches in healthcare.

There is a new mRNA COVID-19 vaccine, but there is no evidence to support its effectiveness or safety in human trials. Additionally, several studies from different countries suggest that these vaccines may actually increase the risk of contracting COVID-19 over time. This is concerning and not a typical outcome.

Every childhood vaccine will be mRNA, becoming gene therapies that alter genetics without re-approval. COVID vaccines were profitable data and experimentation tools, but the real danger is the continued genetic tinkering via mRNA integration into all vaccines. The speaker is now anti-vaxx and will not get any more vaccines for themselves or their family because all vaccines are being redesigned to include gene therapies, driven by profit.

Our company is embracing cell and gene therapy, which has the potential to make a significant impact. The mRNA vaccines are a prime example of this. Just a couple of years ago, if we had asked the public if they would be willing to undergo gene or cell therapy, the majority would have refused. However, the pandemic has changed people's perspectives and made them more open to innovative solutions.

mRNA vaccines code for a small part of viral proteins, usually a single antigen. A single mutation can make the vaccine ineffective. This drives antigenic shift, where the vaccine encourages new mutations, prolonging pandemics as the virus mutates to escape the vaccine's protection. Millions caught the Omicron variant despite vaccination because a single mutation can render mRNA vaccines ineffective. The same risk applies to the flu.

Technology is being rapidly advanced and implemented in humans, particularly messenger RNA vaccines. These advancements are being fast-tracked, and it's important to acknowledge that our food species will also be affected by these vaccines.

- The m n r m r n a technology was a radical qualitative leap forward in technology. - The mRNA is a type of vaccine. - The reason it was called a scene was because was a brand name that had a track record of safety, and shoehorning it in that was one of the ways to make sure that people weren't terrified of the technology. - It bears very little resemblance to anything that went before that. - There are different types that they didn't have to contend with the fact that it wasn't the same technology. There are different technologies. - There certainly are. That are different technologies.

All childhood vaccines will soon be mRNA-based gene therapies, without requiring reapproval. This means that getting any type of vaccine will alter a person's genetics. The focus is now on integrating mRNA into all vaccines, which raises concerns about tinkering with genes. The speaker strongly opposes vaccines and vows not to get any more, emphasizing the financial interests involved in this shift.

Two years ago, most people would have refused gene or cell therapy, but the pandemic has changed perceptions of innovation. The COVID vaccine is not a traditional vaccine as it doesn't provide immunity or prevent transmission. The Pfizer vaccine wasn't tested for transmission prevention before its release due to the urgency. Vaccinated individuals can still get COVID-19. Countries with rapid mass vaccination have seen increased infections and deaths. A study from the Cleveland Clinic suggests that the more shots received, the higher the risk of getting COVID. Vaccination puts evolutionary pressure on the virus, leading to mutations. Epidemiological analysis shows a significant number of deaths related to the vaccines, with dangerous mechanisms of action and consistency with other fatal conditions. Temporal relation is also evident, with many deaths occurring shortly after vaccination.

Two years ago, most people would have refused gene or cell therapy, but the pandemic has changed that. mRNA vaccines are a prime example of this shift towards innovation in healthcare.

We are working on developing new vaccines like TB and HIV using mRNA technology to make them high quality and low cost. Current COVID vaccines are not perfect, so we are working on new versions with longer-lasting protection for diseases like measles and tuberculosis. The mRNA technology also shows promise for cancer vaccines and rapid adaptation to future pandemics. We are even exploring using this technology for animal vaccines.

We are generating real-time data on mRNA vaccines, which have been in development for years due to side effects. Pfizer and Moderna used the pandemic to accelerate their development. The collaboration with BioNTech on flu led to the quick rollout of the mRNA vaccine. Clinical trials skipped phases, causing uncertainty. Concerns arise about vaccine distribution and the need for booster shots. Politics play a role in decision-making.

The speaker suggests that prior to the pandemic, a survey asking the public about willingness to receive gene or cell therapy would have likely resulted in a 95% refusal rate. They believe the pandemic has opened people's minds to innovation in a way that was previously impossible, using mRNA vaccines as an example.

Every childhood vaccine will be mRNA, becoming gene therapies that alter genetics without re-approval. COVID vaccines were profitable data and experimentation tools, but the danger lies in continued genetic tinkering. mRNA is being integrated into every vaccine. Therefore, no vaccines should be taken. All vaccines are being redesigned to include gene therapies because there is so much money in it.

I've been involved in over 50 vaccines, including mRNA vaccines. mRNA is like DNA, giving cells instructions to make proteins. This technology was originally for gene therapy, now used for vaccines. It's a new, experimental technology never used in humans before COVID. Animal studies were skipped for COVID vaccines, a novel approach.

Making mRNA is easy and cheap, which is the key. In the next 5 years, advancements are possible with lipid nanoparticles and their self-assembly. This nano construction surpasses our technological expectations.

The mRNA platform is effective but has a flaw: it can cause autoimmune disorders by producing foreign proteins in cells. The challenge is to target only specific cells and avoid damage to vital organs. The pandemic allowed the emergency use authorization of mRNA vaccines, bypassing safety measures. However, a large portion of the population has already accepted this technology. To address the issue, a solution could be to replace the spike protein with a different protein that doesn't have flaws. But if the problem lies in any foreign protein transcribed by cells, the immune system may still target vital organs.

We are in a digital and scientific revolution, hacking the software of life with mRNA. Our body is made of organs, organs of cells, and in each cell is messenger RNA transmitting DNA information to proteins. This "operating system" can be altered to impact diseases like the flu and cancer. For instance, instead of injecting virus proteins for a flu vaccine, mRNA instructions can teach the body to make its own protection. This mRNA technology has vast potential for disease prevention and treatment.

We discussed pandemic readiness and the speed of mRNA technology. I proposed a simulation to create a vaccine within 60 days, which was initially met with skepticism. However, due to our work on personalized cancer vaccines, we were prepared. When news of a new coronavirus emerged, we quickly got the sequence and began working on a vaccine. The conversation shifted to the need for disruptive entities to accelerate vaccine development, moving away from traditional methods like egg-based production. The urgency for innovative solutions to address outbreaks was emphasized.

The emergency use authorization (EUA) was crucial for normalizing the mRNA platform, which was seen as a significant advancement in vaccine technology. The fear surrounding COVID-19 helped facilitate acceptance of this new approach, despite existing treatments that could have mitigated the pandemic's impact. If doctors had been allowed to explore effective treatments, the reliance on mRNA vaccines would have been diminished, creating a control group that could reveal potential harms. While the EUA was important, it wasn't strictly necessary; they could have navigated around it. The rollout of the mRNA platform aimed to reshape public perception, and the legal complexities surrounding the EUA provided a layer of immunity for those involved. The backlash and discussions about vaccine injuries may complicate future implementations of this technology.

Using mRNA technology similar to that used for COVID, researchers are taking biopsies of a patient's cancer, extracting protein, and reintroducing it into the patient's cells. In clinical trials, 10,009 humans have been treated. All 10,009 are now cancer free. The researchers claim to have cured cancer.

In a 2016 interview, the CEO of Moderna emphasized the importance of using lipid nanoparticles to deliver RNA molecules effectively. However, repeated doses of these nanoparticles can lead to dangerous side effects, as seen in past abandoned technologies by big companies like Merck and Novartis. The difficulty of getting RNA into cells without causing harmful side effects was also highlighted.

Our company is embracing cell and gene therapy, which has the potential to make a significant impact. mRNA vaccines are an example of this type of therapy. Two years ago, if we had asked the public if they would be willing to undergo gene or cell therapy, the refusal rate would have been around 95%. However, the pandemic has made people more open to innovation in ways that were previously unimaginable.